Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$592.1M-14.6%$693.2M+6.2%$653M+0.2%$651.6M+11.3%$585.4M-12.3%
$282.7M-18.8%$348M+12.4%$309.6M+1.1%$306.3M+9.6%$279.4M-14.2%
$309.4M-10.4%$345.2M+0.5%$343.4M-0.6%$345.3M+12.8%$306M-10.5%
52.3%+2.5pp49.8%-2.8pp52.6%-0.4pp53%+0.7pp52.3%+1.0pp
$62.9M-10.5%$70.3M-1.4%$71.3M+17.9%$60.5M-17.7%$73.5M-7.7%
$212.4M-3.9%$221M+6.9%$206.8M-0.4%$207.7M-0.5%$208.8M+2.4%
$34.1M$65.3M-15.3%$77.1M+225%$23.7M-59.3%
5.8%10%-1.8pp11.8%+7.8pp4%-4.7pp
$12.3M+1.7%$12.1M-1.6%$12.3M-2.4%$12.6M+5.0%$12M-1.6%
$24.2M-15.4%$28.6M+245%$8.3M-48.8%$16.2M-56.5%$37.2M+89.8%
-$689.8M-174%$929.2M+316%-$431.1M-204%$414M+396%$83.4M+109%
-$162.7M-178%$209.2M+335%-$89.2M-193%$96.2M+396%$19.4M+110%
-$19.55-174%$26.39+308%-$12.70-209%$11.67+410%$2.29+109%
$80.9M$116.8M-5.0%$122.9M+84.0%$66.8M
13.7%17.9%-1.0pp18.9%+7.5pp11.4%
$34.1M-96.4%$941.3M+1,342%$65.3M-15.3%$77.1M+225%$23.7M-59.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s revenue?
Bio-Rad Laboratories, Inc. (BIO.B) generated $2.6B in revenue over the trailing twelve months, up 1.9% year over year.
Is Bio-Rad Laboratories, Inc. profitable?
Bio-Rad Laboratories, Inc. reported $168.8M in net income over the trailing twelve months, a 6.5% net margin.
What are Bio-Rad Laboratories, Inc.'s profit margins?
Gross margin is 51.9% and operating margin is 8.8%, with a 6.5% net margin.
What is Bio-Rad Laboratories, Inc.'s earnings per share?
Bio-Rad Laboratories, Inc.'s diluted EPS over the trailing twelve months is $5.81.
Where does Bio-Rad Laboratories, Inc.'s income statement data come from?
Every line is extracted from Bio-Rad Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.